Topics
Glioblastoma | Treatment | Targeted therapy | Bevacizumab | Erlotinib
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Bevacizumab > Erlotinib
Lee J, Sim J, Lee YG, Lee GW, Jung HA, Kim KP, Kim TY, Ryu H, Ryu
MH, Ahn MS, Kwon M, Keam B, Bae JM, Kim S, Koo H, Kim SY, Kim JH,
Lee S.
Erlotinib
plus bevacizumab in EGFR-amplified metastatic solid tumors:
results from the KOSMOS I, II study of molecular profiling-guided
therapy in advanced cancers.
Int
J Clin Oncol. 2026 Jun 15. doi:
10.1007/s10147-026-03080-5. PMID:
42298055. Trial
registration ID: NCT05525858.
ˍ